CNS Pharmaceuticals Statistics
NASDAQ: CNSPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.35-0.08 (-1.47%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
CNS Pharmaceuticals by the numbers
CNS Pharmaceuticals has a market capitalization of $7.8 million based on 1.46M shares outstanding. With trailing EPS of $-17.90, CNS Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% below its 50-day average and 14.9% above its 200-day average.
Average daily trading volume is 6.40K shares, or about $34,261 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CNSP valuation vs. peer median
| Metric | CNSP | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.82M | $7.55M | +4% |
| Avg. volume | 6.40K | 229.09K | -97% |
Peer median across 8 companies: AZTR, FBLG, APUS, LGVN, SNGX, CURX, SKYE, TRAW.
Valuation
- Market cap
- $7.82M
- EPS (TTM)
- $-17.90
- Shares outstanding
- 1.46M
Price and trading
- Previous close
- 5.43
- Open
- 5.36
- Day range
- 5.35 – 5.36
- 52-week range
- 1.90 – 10.54
- Beta
- —
- Volume
- 1.74K
- Average volume
- 6.40K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 7.82M
- Forward Pe
- -13.72
- Eps
- -17.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.54
- Week52 Low
- 1.90
- Avg Volume
- 6,404.00
- Shares Outstanding
- 1.46M
- Ma50
- 5.48
- Ma200
- 4.66
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -49.24%
- Pct From52w Low
- 181.58%